Drug trial shows efficacy in treating anemia in chronic kidney disease patients without dialysis
Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease
PDF) Roxadustat in treating anemia in dialysis patients (ROAD): protocol and rationale of a multicenter prospective observational cohort study
Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies | springermedizin.de
Landmark Trials in Anemia & Kidney Disease - Renal Fellow Network
Phase 3 Study of Roxadustat to Treat Anemia in Non–Dialysis-Dependant CKD - ScienceDirect
A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study - ScienceDirect
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement | Semantic Scholar
JCM | Free Full-Text | Current Status of Renal Anemia Pharmacotherapy—What Can We Offer Today
Treatment of Renal Anemia with Roxadustat: Advantages and Achievement | Semantic Scholar
Frontiers | Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis | NEJM
Roxadustat | PDF | Chronic Kidney Disease | Anemia
Clinical trial paper that made anemia drug look safer than it is will be retracted – Retraction Watch
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis | NEJM
Roxadustat Does Not Affect Platelet Production, Activation, and Thrombosis Formation | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Anemia in Chronic Kidney Disease: From Pathophysiology and Current Treatments, to Future Agents
